Comparison of the Effects of TIVA vs VIMA on Content of GSK-3beta in Leucocytes in On-pump Patients

计划入组 10 人 · 首次发布于 2016 年 2 月 19 日

Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

计划入组 30 人 · 首次发布于 2017 年 12 月 26 日

Phosphatidylinositol 3-kinase (PI3K) Alpha iNhibition In Advanced Breast Cancer

计划入组 38 人 · 首次发布于 2015 年 7 月 23 日

Alkaline Phosphatase

Program 3 Phosphatase (Ambagon Therapeutics, Inc.)

bovine alkaline phosphatase

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Immuno Cure 3 Limited

Onco-Innovations Reports Favorable Safety Profile for Novel PKNP Cancer Treatment Technology

Onco-Innovations Initiates Manufacturing of PNKP Inhibitor for Preclinical Testing

Onco-Innovations Partners with University of Alberta to Advance PNKP Inhibitor Research for Glioblastoma Treatment